and numerous other membrane remodeling processes. Moreover, dynamin is a promising target for therapeutic intervention in chronic kidney diseases (CKDs). We want to provide the basis for novel strategies

: Prof. Dr. Hansmann, Pediatric Cardiology, OE 6730, project: Stem cell and anti-miR-mediated therapeutic interventions for pulmonary vascular disease and right ventricular failure Final exam June 2017

A. Rempen, H. Steiner, S. Tercanli, J. Wisser, K. S. Heling Gynäkologische Dysplasie-Einheit A Therapeutic Antigen-Presenting Cell-Targeting DNA Vaccine VB10.16 in HPV16-Positive High-Grade Cervical In

bacteria and the lack of effective antiviral drugs represent a major problem. In particular, new therapeutic approaches are urgently needed for intracellular infections caused by facultative intracellular

Helmholtz Center Munich 13.12.2023 REBIRTH Kolloquium (1 pm s.t., online Vortrag) ‘RNA-based therapeutic strategies for liver injuries’ Prof. Dr. Amar Deep Sharma, Department of Gastroenterology, Hepatology [...] Clinic of Pneumology and Infectiology, MHH ´Genetic skewing of macrophage function to enhance the therapeutic properties’ Schifaa Abdin (Group of Prof. Dr. Nico Lachmann), Department of Applied Stem Cell and [...] for Kidney and Hypertension Diseases, MHH ´Relevance of cardiovascular risk factors for novel therapeutic approaches´ Prof. Dr. Rabea Hinkel, German Primate Centre, Leibniz Institute for Primate Research

Engineering at the same institute. Professor Figueiredo is highly interested in cell and gene therapeutic approaches in the field of transfusion and transplantation. She has a long-term expertise in the

Tsiavaliaris. Small molecule effectors of myosin motor proteins: novel pharmacological agents with therapeutic potential. Nov. 2018, Organisch-Chemisches Kolloquium der TU Dresden , Prof. Hans-Joachim Knölker

selected T-cells are addressing the burden of infection in patients often having no alternative therapeutic option available. Transplant Engineering This area of research focuses on the genetic engineering

gene expression of Chlamydia trachomatis during persistent infection. A study to establish new therapeutic pathways and a better understanding of the pathogenesis of reactive arthritis Final exam November

Nidhi Jyotsana INDIA supervisor: Dr. Heuser, Haematology and Oncology, OE 6860, project: MN1 as a therapeutic target in AML Final exam June 2015 Piyushkumar Kapopara INDIA supervisor: Dr. Bavendiek, Cardiology